TD Waterhouse Canada’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
TD Waterhouse Canada's NVS Position: Q1 2026 in Review
TD Waterhouse Canada increased its Novartis (NVS) stake by 157% in Q1 2026, buying an estimated $7M and bringing the position to 74,666 shares worth $11.6M. The position accounts for 0.03% of the portfolio, ranked #249.
TD Waterhouse Canada first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- TD Waterhouse Canada held 74,666 shares of Novartis worth $11.6M as of Q1 2026.
- TD Waterhouse Canada bought 45,644 Novartis shares in Q1 2026, an estimated $7M.
- Novartis made up 0.03% of TD Waterhouse Canada's portfolio in Q1 2026, its #249 holding.
- TD Waterhouse Canada first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.